Benzinga · Mar 2, 2026
RadNet Makes $270 Million Bet On AI Future With Gleamer Buyout
RadNet (RDNT) reports record Q4 revenue and adjusted EBITDA, beating estimates and announcing acquisition of Paris-based AI firm Gleamer.
XH
NYSE · XHS
SPDR S&P Health Care Services ETF
Financial Services · Asset Management
$137.61
Down-$2.96 (-2.11%)
Updated Oct 19, 2026, 1:23 AM
SID Score
4.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 89.65M
- P/E ratio
- —
- Dividend yield
- 0.19%
- 52-week range
- $98.15 – $141.21
- Volume
- 72.93K
- Avg. volume
- 7.02K
Price performance · XHS
XHS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 16, 2026
XHS closed at $137.61 after 20 trading sessions, up 1.68% for the selected period.
- Last close
- $137.61
- Period change
- +1.68%
- Period low
- $131.52
- Period high
- $140.57
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | $141.13 | $141.21 | $137.08 | $137.61 | 72.93K |
| Oct 15, 2026 | $139.32 | $140.57 | $138.9415 | $140.57 | 21.52K |
| Oct 14, 2026 | $136.85 | $138.21 | $136.85 | $138.21 | 22.33K |
| Oct 13, 2026 | $138.00 | $138.28 | $135.94 | $136.8297 | 27.51K |
| Oct 12, 2026 | $135.86 | $137.2371 | $135.86 | $137.2371 | 9.59K |
| Oct 9, 2026 | $134.63 | $136.61 | $134.10 | $136.03 | 12K |
| Oct 8, 2026 | $134.09 | $134.73 | $132.90 | $134.62 | 72.51K |
| Oct 7, 2026 | $134.38 | $135.89 | $133.88 | $134.42 | 18.06K |
| Oct 6, 2026 | $136.39 | $137.36 | $134.82 | $135.19 | 29.03K |
| Oct 5, 2026 | $133.03 | $136.14 | $132.85 | $135.46 | 24.32K |
| Oct 2, 2026 | $131.96 | $133.54 | $131.96 | $133.36 | 19.63K |
| Oct 1, 2026 | $132.00 | $133.075 | $130.99 | $131.52 | 179.24K |
| Sep 30, 2026 | $133.30 | $133.64 | $131.9007 | $132.29 | 63.9K |
| Sep 29, 2026 | $133.81 | $134.52 | $132.02 | $133.21 | 96.37K |
| Sep 28, 2026 | $133.96 | $135.0999 | $133.96 | $134.1294 | 10.54K |
| Sep 25, 2026 | $133.26 | $135.74 | $133.26 | $134.8172 | 34.91K |
| Sep 24, 2026 | $133.99 | $134.1705 | $132.7498 | $133.238 | 14.94K |
| Sep 23, 2026 | $135.58 | $135.58 | $133.81 | $133.81 | 13.55K |
| Sep 22, 2026 | $135.43 | $136.888 | $135.43 | $136.2269 | 9.7K |
| Sep 21, 2026 | $136.34 | $136.89 | $135.09 | $135.33 | 178.73K |
Latest XHS news
The latest Smart Investors Daily articles mentioning XHS.
Stock researchCompany · Overview
Company
Market Activity
Research & News
XHS research
Overview
Company profile and research snapshot.
Company profile
In seeking to track the performance of the S&P Health Care Services Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the health care services segment of the S&P Total Market Index ("S&P TMI").
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Benzinga · Jan 27, 2026
Clover Health (CLOV) Slides As Trump Medicare Advantage Shock And UnitedHealth Earnings Hit Insurer Sentiment
Clover Health Investments is trading lower Tuesday afternoon after the Trump administration proposed flat MA payment rates for 2027.
zacks.com · Nov 24, 2025
Best-Performing ETFs of Last Week: Healthcare Rules
Healthcare and biotech led last week's winners, with EPHE, BBC, HELX, XHS and SURI topping ETF gains as markets slid on AI worries and Fed uncertainty.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
